February has several important catalysts for companies in the biotech; these have the potential to move these stocks significantly in the short term. Dynavax is going in front of a CDC advisory committee in search of a recommendation for Heplisav-B, its adult Hepatitis B vaccine.
Over a vigorous dissent, the US Court of Appeals for the Federal Circuit issued a per curiam order denying a petition for panel rehearing and en banc rehearing of its earlier inequitable conduct decision. Regeneron Pharmaceuticals, Inc. v.
Beverly Armstrong made her career as a biotech industry executive, but her passion was rugby, which she played semi-professionally for 15 years. When she returned home, she began brewing her own session beers and eventually opened up her own brewing company, called Brazo Fuerte.
Pfizer's fourth-quarter profit soared to $12.27 billion thanks to a huge tax benefit related to the U.S. tax system overhaul. The biggest U.S. drugmaker on Tuesday reported an $11.34 billion benefit, mainly from recalculating deferred tax liabilities.
In a story Jan. 29 about American Express CEO Kenneth Chenault, The Associated Press erroneously identified the Fortune 500 drug company that is led by a black CEO. Merck & Co., not Pfizer, has a black CEO.
This 1973 electron microscope image made available by the Centers for Disease Control and Prevention shows influenza virus particles. Doctors have long believed flu can trigger fatal heart problems, but previous studies were not considered rigorous.
U.S. health officials say the flu blanketed the U.S. again last week for the third straight week. The Centers For Disease Control and Prevention says 49 out of 50 states are seeing "widespread" flu activity.
U.S. health officials say the flu blanketed the U.S. again last week for the third straight week. The Centers For Disease Control and Prevention says 49 out of 50 states are seeing "widespread" flu activity.
Watson Pharmaceuticals, now part of Israel-based Teva Pharmaceuticals, will make the payment after the state Supreme Court upheld a verdict. Lawyers hired by Hood sued Watson in one of a series of suits claiming drugmakers wrongly inflated prices paid by the state-federal Medicaid health insurance program.
A federal agency reports that Illinois was consistently in the top five states nationwide for cold-related deaths per year from 1999 until 2016. Data from the Centers for Disease Control and Prevention says Illinois also ranks 15th nationally on average during the same time period for cold deaths per 100,000 people.
On remand from the Supreme Court of the United States, the US Court of Appeals for the Federal Circuit held that under the Biologics Price Competition and Innovation Act of 2009 , state law claims and remedies are not available in biosimilar patent litigation. Amgen Inc. v.
An analysis by The Arizona Republic found that Mohave County dispensed 127.5 opioid prescriptions per 100 residents that year. Those numbers from the Centers for Disease Control and Prevention show that the vast rural county in northwest Arizona was the state's most prolific opioid prescriptions county by that measure.
By Memorandum Opinion entered by The Honorable Gregory M. Sleet in Genentech, Inc. et al. v. Amgen Inc. , Civil Action No.
Shares in Belgian biotech company Ablynx surged on Monday after it agreed to be bought by French pharmaceutical group Sanofi for 45 per share in cash, or 3.9bn. Sanofi's offer trumped an offer from Novo Nordisk earlier this month of up to 30.50 a share.
According to Zacks, "Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria lung infections and cystic fibrosis patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company's inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension , a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
The brokerage currently has a $68.00 price objective on the biotechnology company's stock, up from their prior price objective of $45.00. First Analysis' price objective suggests a potential upside of 0.34% from the stock's previous close.
A number of other research analysts also recently commented on the company. Jefferies Group reiterated a buy rating and issued a $54.00 price objective on shares of The Medicines in a report on Thursday, October 26th.
Gähnend langsame Internetverbindungen sind genauso nervig wie Kopfschmerzen. Stehen mehrere WLAN-Netzwerke zur Verfügung, dann sollte man zu einem Schnelleren wechseln. Das kleine Tool Wifinian zeigt dir auf einen Blick, welches Netzwerk am schnellsten arbeitet.
Wifinian ist bei GitHub kostenlos erhältlich und läuft mit Betriebssystemen ab Windows 7. Das Tool scannt die Umgebung und listet die alle WLAN-Netzwerke, sortiert nach Signalstärke auf. Diese wird nicht nur als Balkendiagramm abgebildet, sondern auch mit einer genaueren Prozentangabe.
Wenn die Signalstärke mal nicht zu deiner Priorität gehört sondern eine größere Bandbreite, dann kannst du über den Button Reorder die Prioritäten ändern.
Die Bedienung ist sehr einfach und übersichtlich gehalten. Außerdem klinkt sich Wifinian in die Taskleiste ein und lässt sich für einen Zwischendurch-Scan oder für einen unkomplizierten Netzwerkwechsel schnell mal starten.
Earlier this month, Michael Chan and several colleagues flew 11 hours to San Francisco to represent Hong Kong's stock exchange for the first time at JPMorgan Chase & Co's global Healthcare Conference, attended by more than 10,000 institutional investors, founders of health care start-ups and industry executives. Speaking at a panel attended by 200 people, Chan - senior vice-president of issuer services at Hong Kong Exchanges & Clearings Limited, the bourse operator - put forward a pitch for biotech companies to raise capital in Hong Kong.
Shares of AmerisourceBergen Corp. have been given a consensus rating of "Buy" by the nineteen analysts that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, ten have given a buy recommendation and one has issued a strong buy recommendation on the company.
We collect zip code so that we may deliver news, weather, special offers and other content related to your specific geographic area. We have sent a confirmation email to {* data_emailAddress *}.
Illumina, Inc. has been given a consensus rating of "Buy" by the twenty-five ratings firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and fourteen have given a buy recommendation to the company.
Das Handys bei Dieben eine begehrte Beute sind, ist ja hinlänglich bekannt. Auch die Polizei wird nicht müde, immer wieder darauf hinzuweisen. Die Aufklärungsquote bei über 200.000 gemeldeten Handydiebstählen pro Jahr ist zudem äußerst gering. Die Dunkelziffer dürfte weitaus höher liegen. Vor einiger Zeit hat die Polizei in München einen Code per Facebook veröffentlicht, der bei der Wiederbeschaffung sehr nützlich sein kann.
Der Code *#06# in die Telefon-App eingetippt, zeigt eine 15-stellige Zahl (Handy-Seriennummer) an, die du dir notieren sollst. Am besten ganz analog auf einem Blatt Papier oder direkt auf der Rechnung, die du dann abheften kannst.
Kommt dir das bekannt vor? Kein Wunder, denn bei dieser 15-stelligen Zahlenfolge handelt es sich um die IMEI-Nummer deines Smartphones. Da sie einmalig ist, hilft dies der Polizei, dir dein Eigentum wieder zurück zu geben, falls bei einer Beschlagnahmung dein Handy gefunden wurde.
Zugegeben, die Überschrift unseres Artikels ist ironisch gemeint, der Tipp mit der IMEI sollte aber auf jeden Fall ernst genommen werden.
Die IMEI-Nummer findest du übrigens auch auf dem Karton des Handys, der Rechnung und auf dem Gerät selber, unter der Abdeckung der Geräterückseite.
Im Falle eines Diebstahls fragen viele Betroffene bei der Polizei, ob das Handy von den Beamten nicht geortet werden könne. Leider ist die Ortung eines Telefons aus rechtlichen Gründen nicht möglich.
Hierzu ist eine richterliche Anordnung erforderlich, die bei (Taschen-) Diebstählen normalerweise nicht erteilt wird.
Die Polizei empfiehlt die Aktivierung der Ortungsfunktion des Gerätes oder die Installation einer Ortungsapp. Für Android-Handys ist AndroidLost empfehlenswert und für iPhones empfehlen wir die Apps Mein iPhone suchen und Meine Freunde suchen. Nur so ist es für die Polizei möglich, dein Telefon im Falle eines Diebstahls zu orten.
Also, nach dem Kauf eines Smartphones direkt die IMEI auslesen und notieren. Damit erhöhst du die Chance, nach einem Diebstahl dein Telefon wiederzubekommen.
In this Jan. 12, 2018, file photo, Ana Martinez, a medical assistant at the Sea Mar Community Health Center, gives a patient a flu shot in Seattle. Flu season continues to get worse, as this has become the most intense the country has seen since a pandemic strain hit nine years ago, U.S. health officials said on Friday, Jan. 26, 2018.
Just as Elvis Presley slipped out of view before staging a televised comeback that carried him to even greater heights, big biotechnology stocks could be headed for a revival of their own.
Case Name : Eli Lilly and Co. v. Perrigo Co. , No. 2016-2555, -2614, 2017 U.S. App.
Apotex Inc. president and CEO Jeremy Desai resigned effective immediately Friday from the generic drug giant founded by the recently deceased billionaire Barry Sherman. Desai's resignation comes as he faces allegations in a U.S. lawsuit from Teva Pharmaceutical Industries Ltd. for allegedly accepting trade secrets from a Teva employee that he was thought to be in a romantic relationship with.
A deadly flu epidemic spreading across the nation has now claimed the lives of 37 children, the U.S. Centers for Disease Control and Prevention said Friday. The astonishing number the of patients the CDC expects to see by the end of the season, on Channel 2 Action News at 5 p.m. And the CDC said more Baby Boomers, those 50-64 years old, are at a higher risk of getting the flu this year than in previous years.
U.S. stocks powered to their biggest gain in almost nine months Friday as drugmakers and technology companies surged. Investors were cheered that President Donald Trump appeared to take a more positive tone on international trade.
"In the 2017 postseason, Morton introduced himself to a national audience in the biggest way possible, winning Game 7 of the World Series for the Houston Astros." - Connecticut Mag Read more about the 2018 class of 40 Under 40 at ConnecticutMag.com "In the 2017 postseason, Morton introduced himself to a national audience in the biggest way possible, winning Game 7 of the World Series for the Houston Astros."
"Farmers... )--Sleep Number Corporation will release results for the fourth quarter and full year ended Dec. 30, 2017, after close of the regular trading session on Fe... )--PAVmed Inc. , a highly differentiated, multiproduct medical device company, today announced that it has completed the sale of 234,540 shar... )--FVCBankcorp Inc. today reported fourth quarter 2017 operating earnings of $3.0 million, or $0.25 diluted earnings per share, compared to ... )--Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that the European Medicines Agency has accepted the Mar... )--CSB Bancorp, Inc. : Fourth Quarter Highlights Quarter Ended Quarter Ended December 31, 2017 December 31, 2016 Diluted earnings per shar... )--The J.G. Wentworth CompanyA today announced it has successfully completed its reorganization in coordination with its lenders... )--AECOM, a ... (more)
U.S. Centers for Disease Control and Prevention statistics show that more than 700,000 children are referred to child protective agencies as a result of abuse or neglect in the U.S. each year. According to Purva Grover, M.D., a pediatric emergency physician at Cleveland Clinic Children's, child abuse is something that unfortunately pediatricians and emergency room physicians are always on the lookout for, but parents need to know the warning signs of physical abuse too, especially when their children are left in the care of others.
Some of the biggest names in biotech have formed a "tribute committee" to honor the legacy of Henri Termeer - by raising $1 million to erect a life-size sculpture of the late Genzym e CEO in Cambridge. The effort was announced last week by the Henri A. Termeer Tribute Committee, a newly-formed group whose members include Alnylam Pharmaceuticals CEO John Maraganore , Vertex Pharmaceuticals founder Joshua Boger , and Biogen board chair Stelios Papadopoulos .
Rechtzeitig zum Start der olympischen Winterspiele in PyeongChang am 09. Februar 2018 werden von Unitymedia neue Sportsender freigegeben. Ein Teil dieser Sender ist für alle Nutzer frei empfangbar.
Drei EUROSPORT Olympic Pop-up-Channels werden für alle Zuschauer im Unitymedia Einzugsbereich frei empfangbar sein. Die Pop-up-Channels stehen aber nur für diese Olympiade zur Verfügung und werden danach wieder abgeschaltet. Du findest sie auf den Senderplätzen 254, 255 und 256.
Für diese drei Sender gibt es auch eine gute Neuigkeit. Du benötigst für sie nur die HD-Option von Unitymedia, ein Sky-Abonnement ist für den Empfang nicht mehr notwendig. Die Senderplätze von Eurosport 360 HD sind 244, 245 und 246.
Auch für Kunden von Sky, die einen Sky+ Pro UHD-Rekorder besitzen, wird die Angebotspalette um zwei Sender erweitert. Sky Sport Bundesliga UHD ist dann auf Senderplatz 210 der Sky UHD Box empfangbar und der Sender Sky Sport UHD findest du auf Kanal 202.
Es gibt neben den ganzen Sportsendern zwei weitere, frei empfangbare Sender. Anixe HD sendet auf Platz 210 und der christliche TV-Sender HOPE CHANNEL ist auf Senderplatz 434 zu finden.
Außerdem wird das Empfangsgebiet von Studio 47 auf Mülheim, Oberhausen und Wesel ausgedehnt. Bisher wurde der Duisburger Sender nur im westlichen Ruhrgebiet und am Niederrhein ausgestrahlt (Senderplatz 382).
Alle genannten Änderungen treten am nächsten Unitymedia-Change-Day am 30. Januar 2018 in Kraft.
In September 2017, Saint Regis Mohawk Tribe moved to dismiss six instituted trials on petitions filed by Mylan Pharmaceuticals Inc. Those petitions challenged six patents that, at the time the petitions were filed, belonged to Allergan, Inc. The Tribe argued that on "September 8, 2017, Allergan, Inc. assigned all six Patents-at-Issue in this case to the Tribe." And that the "Tribe concurrently granted back an exclusive limited field-of-use license."
Cohen & Steers issued its earnings results on Wednesday. The asset manager reported $0.55 earnings per share for the quarter, topping analysts' consensus estimates of $0.54 by $0.01, Bloomberg Earnings reports.
U.S. stocks are climbing Thursday as health care companies including Biogen and Celgene rise and chipmakers and other technology companies bounce back from their losses a day ago. Airlines continue to take steep losses as investors worry about rising costs and the possibility of falling fares.
This 1973 electron microscope image made available by the Centers for Disease Control and Prevention shows influenza virus particles. Doctors have long believed flu can trigger fatal heart problems, but previous studies were not considered rigorous.
The Senate is set to vote to confirm Alex Azar on Wednesday as the next Department of Health and Human Services secretary. A top executive with Eli Lilly for nearly nine years, Azar would replace Tom Price, who resigned amid a scandal over his use of private planes while leading the department.
It was a Monday of dealmaking, with insurance giant AIG announcing a $5.56 billion agreement to acquire Bermuda-based Validus Holdings [ ]; biotech biggie Celgene Corp. agreeing to buy Juno Therapeutics for roughly $9 billion in a move to expand its blood-cancer drugs [ ]; and luxury firm Richemont offering $3.3 billion to bring Yoox Net-A-Porter - "one of the world's most disruptive e-commerce companies" - into its stable to Italy's Ferrero for $2.8 billion last week - to make further changes, including dropping its stake in cosmetics giant L'Oreal NY state judge Marcy Friedman has refused DZ Bank's attempt to conduct a bellwether trial in its fraud suit against Morgan Stanley over toxic RMBS, suggesting that that the plaintiff-selected cases "wouldn't resolve things any more efficiently" White Collar Watch offers up something of an existential question for us on the issue of financial ... (more)
Insmed Incorporated announced today that it priced its registered underwritten public offering of $400 million aggregate principal amount of its 1.75% convertible senior notes due 2025. Net proceeds from the offering, after deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately $387.3 million.
Puma Biotechnology shares dropped 25% to $68 after hours. The company said the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a "negative trend vote" for the drug neratinib to treat early stage HER2-positive breast cancer, meaning it will not likely get approval in a decision scheduled in February, and that additional steps would likely be needed to get a positive approval.
Johnson & Johnson posted a rare quarterly loss, a whopping $10.71 billion, due to a $13.6 billion charge related to last month's U.S. tax overhaul. While the loss was expected and the company's adjusted results beat Wall Street expectations, shares fell more than 4.1 percent, an unusually big swing for the health care giant.
Baby making in the U.S. is on the decline, and the makers of diapers and bottles are feeling the pinch. The U.S. birth rate dropped to a historic low last summer, as would-be parents pushed back parenthood.
U.S. stocks are mixed in early trading Tuesday as consumer-focused companies like Netflix and Amazon climb while household goods makers including Johnson & Johnson and Procter & Gamble sink following disappointing quarterly reports. Bond yields are down after rising to three-year highs in the last few days.
This Monday, Aug. 24, 2015, file photo shows the New York Stock Exchange. U.S. stocks are mixed, Tuesday, Jan. 23, 2018, as technology and consumer-focused companies rise but consumer goods makers like Johnson & Johnson take losses.
We collect zip code so that we may deliver news, weather, special offers and other content related to your specific geographic area. We have sent a confirmation email to {* data_emailAddress *}.
This Tuesday, Sept. 13, 2016, file photo, shows a selection of Johnson & Johnson brand first aid products arranged for a photo, in Surfside, Fla.
's stock had its "buy" rating reaffirmed by investment analysts at Cantor Fitzgerald in a note issued to investors on Sunday. They currently have a $15.00 target price on the biopharmaceutical company's stock.
The Medicines and Hospira are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends. Hospira has lower revenue, but higher earnings than The Medicines.
Of the 30 U.S. children who have died from the flu so far this season, some 85 percent had not been vaccinated, said Centers for Disease Control and Prevention Director Dr. Brenda Fitzgerald, who urged Americans to get flu shots amid one of the most severe flu seasons in years. "My message is, if you haven't gotten a vaccine, please get a vaccine.
Celgene Corp.'s $9 billion purchase of Juno Therapeutics Inc. might have Bluebird Bio Inc. feeling like a third wheel. The deal announced on Monday means Bluebird -- which, like Juno, is working on so-called cell therapies that train human immune cells to hunt cancer -- likely loses its most obvious potential deal suitor.
Celgene is on a shopping spree this year: First, it bought Impact Biomedicines for $1.1 billion at the start of the month, and today it announced that it will buy Juno Therapeutics for $87 a share in cash, or $9 billion. Rumors of a Juno deal leaked last week, so some analysts had already come out in favor of the combination .
Kentucky's attorney general on Monday accused drug distributor McKesson Corp. of helping fuel the opioid epidemic by failing to halt shipments of suspiciously large or frequent orders by pharmacies of prescription painkillers. The complaint by Kentucky Attorney General Andy Beshear was filed in a state court and was one of a flurry of lawsuits by states and local governments against opioid manufacturers and distributors seeking to hold them accountable for the U.S. epidemic.
Kentucky's Democratic attorney general has sued a national opioid distributor for allegedly using misleading business practices to flood the state with dangerous and highly addictive prescription painkillers. Andy Beshear announced Monday he has sued the San Francisco-based McKesson Corporation for, among other things, failing to report large volumes of opioid shipments in eastern Kentucky with state and federal authorities.
Clouds are reflected in the U.S. Capitol reflecting pool at daybreak in Washington as day three of the government shutdown continues on Monday. Clouds are reflected in the U.S. Capitol reflecting pool at daybreak in Washington as day three of the government shutdown continues on Monday.
The largest exchange-traded funds to track the biotechnology sector rallied on Monday, surging after a pair of multibillion-dollar deals were announced. surged 3.8% in its biggest one-day percentage gain since June 2017.
The company appears to be on the right track, inking another ENHANZE deal, this time with Alexion. Is the path for growth as promising as it appears? PEG is poised for an important 2018; the prospects for the drug if approved are strong.
Celgene Corp. said on Monday it would pay about $9 billion in cash to acquire the rest of Juno Therapeutics Inc. and gain access to Juno's experimental gene therapy to treat cancer. The $9 billion represents an offer $87 per share to Juno's shareholders and the deal, agreed by both boards, is expected to close in the first quarter of 2018.
Pfizer is scheduled to be posting its quarterly earnings results before the market opens on Monday, January 29th. Pfizer has set its FY17 guidance at $2.58-2.62 EPS.
The brokerage currently has a $111.00 price objective on the stock. Zacks Investment Research 's price target points to a potential upside of 10.93% from the stock's current price.
Equities research analysts forecast that Sanofi SA will report earnings of $0.68 per share for the current fiscal quarter, according to Zacks . Three analysts have provided estimates for Sanofi's earnings.
Transition Therapeutics and Fortress Biotech are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings. 12.1% of Fortress Biotech shares are owned by institutional investors.
Derzeit erhält die Amazon-Alexa-App eine Update, in dem auch die Implementierung der Sprachassistentin Alexa vorgenommen wird. Das hört sich irgendwie komisch an, oder? Mit der Alexa-App ließen sich in der Vergangenheit die Smart-Home-Devices über das Smartphone steuern. Wie bei Amazon Echo, aber ohne Sprachsteuerung. Diese wird der Alexa-App nun hinzugefügt.
Wer bisher die Alexa-Sprachsteuerung auf dem Handy oder dem Tablet nutzen wollte, der musste vorher eine mit Alexa kompatible App, wie beispielsweise Reverb, verwenden. Damit ist nun Schluss.
Ist kein Amazon Echo in Hörweite, dann lassen sich alle Befehle der Sprachsteuerung auch mit der App realisieren. Nur automatisch zuhören kann die Alexa-App nicht. Dazu muss der Button gedrückt werden.
Wenn deine Alexa-App noch keine Sprachsteuerung hat, dann aktualisiere die App. Ist sie danach immer noch nicht vorhanden, wird es vermutlich noch ein paar Tage dauern, da dieses Update in mehreren Wellen ausgeliefert wird.
Vorerst wird leider nur Android unterstützt. Die Updates für iOS-Geräte folgen wohl (viel) später.
Nanosphere is one of 80 publicly-traded companies in the "Advanced Medical Equipment & Technology" industry, but how does it contrast to its peers? We will compare Nanosphere to similar companies based on the strength of its profitability, dividends, risk, valuation, earnings, institutional ownership and analyst recommendations. As a group, "Advanced Medical Equipment & Technology" companies have a potential downside of 3.36%.
's stock had its "buy" rating reissued by investment analysts at Robert W. Baird in a research note issued to investors on Thursday. They currently have a $154.00 price target on the biotechnology company's stock.
Last May 18 - about four months before the deadliest mass shootings in modern U.S. history unfolded on the Las Vegas Strip - gunman Stephen Paddock was thinking about San Diego. On a laptop computer seized from one of his Mandalay Bay hotel rooms after the massacre, authorities found a web search from that Thursday in May for "La Jolla Beach," as well as evidence that he had visited Sandiego.org, the region's tourism website.
Impax Laboratories and Innocoll are both small-cap pharmaceuticals - nec companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations. Innocoll has lower revenue, but higher earnings than Impax Laboratories.
Robert Freedman, vice president and general manager of the tactical solutions strategic business unit for Ball Aerospace, poses for a portrait outside of the Ball Aerospace Manufacturing Center in Broomfield Feb. 13, 2017.
Mit dem neuen iOS 11 werden Bilder und Videos beim iPhone und dem iPad in einem neuen Standard, das den Speicherbedarf reduziert, aufgenommen. Diese beiden Formate sind bisher noch nicht in allen Media Playern und Bildbetrachtungsprogrammen integriert. Das ist aber kein Problem, da es (kostenlose) Tools zur Konvertierung gibt oder man die neuen Formate auf dem Gerät deaktivieren kann.
Die neuen Formate, HEIF (.heic) für Fotos und HEVC (.hevc) für Videos, benötigen bis zu 50 Prozent weniger Speicherplatz. HEIF und HEVC sind Abkürzungen. Sie stehen für High Efficiency Image File Format und High Efficiency Video Coding.
Wer seine Bilder und Videos auf dem PC speichern und/oder ansehen möchte, sollte ein passendes Tool installieren. Leider fehlen noch bei vielen Bildbearbeitungsprogrammen und Video-Playern die erforderlichen Codecs. Auch die älteren Apple-Betriebssysteme sind mit den neuen Formaten nicht kompatibel.
Konvertierungsprogramme sind im Web kostenlos erhältlich. Wir empfehlen den Free HEIC Converter (für Fotos) und den H.265 Converter (für Videos). Beide Programme werden auf der Webseite von Aiseesoft als Freeware angeboten.
Und wer seine Dateien lieber online konvertieren möchte, der kann Bilder auf der Webseite HEIC to JPG und HEVC-Videos bei Convertio umwandeln.
Möchtest du vorerst ganz auf die neuen Formate verzichten, dann schalte HEIF/HEVC auf deinem iPhone/iPad einfach ab.
Tippe auf Einstellungen und dann auf den Eintrag Kamera. Im Bereich Formate aktivierst du anschließend die Einstellung Maximale Kompatibilität. Damit sind HEIF und HEVC deaktiviert und die Aufnahmen erfolgen wieder im altbewährten Format.
DECEMBER 21: The U.S. Capitol is seen as congressional lawmakers worked on a deal to fund the government and avert a shutdown by midnight Friday, on December 21, 2017 in Washington, DC. That funding extension expires at midnight Eastern time Friday, and without another deal the government would begin shutting down.
On January 8, 2018, U.S. Secretary of Agriculture Sonny Perdue presented to President Donald Trump the findings of the Interagency Task Force on Agriculture and Rural Prosperity . The Task Force was established in 2017 following an Executive Order by President Trump to ensure the informed exercise of regulatory authority that impacts agriculture and rural communities.
Industry executives are upbeat about the prospects of China's biotech sector, as Beijing has taken a slew of measures to speed up new drug approval and expect pharmaceutical sales to grow by 15pc from 2019 to 2021 Biotech stocks have the potential to excite and disappoint in equal measure, and investors new to the sector should tread carefully, say investment professionals. Similar to early stage minerals and fossil fuel exploration firms without a profit track record, which are also allowed to list in Hong Kong under separate regulations and disclosure requirements to protect retail investors, biotech companies too are inherently risky.
In 2017, the U.S. Supreme Court in cases such as BNSF Railway Co. v. Tyrrell and Bristol-Myers Squibb Co.
Research analysts at Leerink Swann decreased their Q4 2017 earnings estimates for shares of Amgen in a research note issued on Thursday. Leerink Swann analyst G. Porges now forecasts that the medical research company will post earnings per share of $2.90 for the quarter, down from their prior forecast of $2.93.
Students at Paulding County High School use high-tech equipment in peer-reviewed research projects as part of their biotech learning pathway.
Research analysts at SunTrust Banks upped their FY2019 EPS estimates for shares of Merck & Co., Inc. in a research note issued to investors on Tuesday. SunTrust Banks analyst J. Boris now anticipates that the company will earn $4.39 per share for the year, up from their previous estimate of $4.23.
Paramedics treated the women for smoke inhalation, but they declined to be taken to a hospital, San Diego Fire-Rescue Department spokeswoman Mnica Muoz said.
Dr. Anthony Fauci of the National Institutes of Health says the institution is in a "scramble" to prepare for a potential government shutdown at midnight Friday. Sen. Dick Durbin, D-Ill., followed by Sen. Bob Menendez, D-N.J., walks to the Senate as Congress moves closer to the funding deadline to avoid a government shutdown, at the Capitol in Washington, Thursday, Jan. 18, 2018.
Depositary shares of the up-and-coming Chinese biotech firm BeiGene jumped 15% today, to $118, after the company successfully raised $750 million in a follow-on share offering. BeiGene has promising drugs under development, ample funding, and international partners like Celgene and Boehringer Ingelheim .
Dr. Anthony Fauci of the National Institutes of Health speaks during an AP Newsmaker interview in Washington, Thursday, Jan. 18, 2018. Dr. Anthony Fauci of the National Institutes of Health speaks during an AP Newsmaker interview in Washington, Thursday, Jan. 18, 2018.
Edwards Lifesciences Corp VP Larry L. Wood sold 6,300 shares of Edwards Lifesciences stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $121.00, for a total value of $762,300.00.
Exact Sciences fell from its recent highs after the report of a new blood test that could have a higher sensitivity to detect precancerous lesions. Watching Exact Sciences fall from its recent highs after the report of a new blood test that could have a higher sensitivity to detect precancerous lesions than the company's stool-based cologuard test.
Amgen, Inc. EVP Sean E. Harper sold 1,525 shares of Amgen stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $185.62, for a total transaction of $283,070.50.
A Florida man was sentenced on Wednesday to one year in prison for engaging in insider trading based on a tip he received from an ex-Morgan Stanley broker about Gilead Sciences Inc's planned $11.2 billion purchase of Pharmasset Inc in 2011, prosecutors said. Jay Fung, of Delray Beach, was sentenced by U.S. District Judge Anne Thompson in Trenton, New Jersey, after pleading guilty in March 2016 to conspiracy to commit securities fraud, prosecutors said.
Qiagen and WuXi PharmaTech are both mid-cap biotechnology & medical research - nec companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, institutional ownership, risk and profitability. Qiagen has higher revenue and earnings than WuXi PharmaTech .
Volume topped 270,000 shares more than two hours before the open, compared with the full-day average of about 184,000 shares. Under terms of the collaboration, GlaxoSmithKline will acquire exclusive ownership of Quell technology for markets outside the U.S., while NeuroMetrix will retain exclusive ownership for the U.S. market.
Marina Biotech has entered into a binding license agreement with Autotelic Bio for the exclusive development and marketing outside of the United States and Canada of Marina's IT-103 clinical program. Under the agreement, Autotelic Bio will obtain a perpetual license to have the right and responsibility to begin clinical development of IT-103 for marketing approval in South Korea and territories outside of United States and Canada.
It was a busy day on the hiring front for Arnold & Porter Kaye Scholer , which said Tuesday that it had added Christopher Dodd, the former U.S. senator from Connecticut, and Steve Benz, who was head of litigation for pharmaceutical company Eli Lilly. Dodd, whose tenure on Capitol Hill lives on in the shorthand for the post-financial crisis reforms known as Dodd-Frank, served five consecutive terms in the U.S. Senate before deciding not to run for re-election in 2010.
LAVAL, Que. - Valeant Pharmaceuticals International Inc. says a U.S. District Court judge gave his preliminary approval Tuesday to a US$290-million settlement of lawsuits stemming from the unsuccessful attempted hostile takeover in 2014 of Botox maker Allergan Inc. As part of the deal agreed to in December, Quebec-based Valeant will pay US$96.25 million, with co-defendant Pershing Square Capital Management, L.P. paying the rest.
Three days after a false report of a missile attack on Hawaii seemed the perfect time to help the public for a nuclear disaster. But instead, the Atlanta-based Centers for Disease Control and Prevention changed the top of Tuesday's discussion to the flu epidemic .
Merck & Co Inc's blockbuster drug Keytruda in combination with two chemotherapy drugs was successful as a first line treatment for lung cancer, results from a key late-stage study showed on Tuesday. The results present a challenge to Swiss drugmaker Roche and Merck's U.S. rival Bristol-Myers Squibb Co, both of which are developing key lung cancer combination treatments of their own.
Johnson & Johnson is battling litigation asserting that people contracted mesothelioma, an asbestos-related disease, from years of using the company's talc powders-Johnson's Baby Powder and Shower to Shower, a product J&J sold to another company in 2012. J&J says the powders are perfectly safe and do not contain asbestos.
Penny stocks are stocks that trade for less than $5 per share. They're popular because of their ability to triple or quadruple your investment in a matter of days.
Donald Trump says his corporate tax cuts are setting off a domino effect that will finally end the long, lean years for American wage-earners. And there are a handful of very public commitments to increase pay -- from Walmart to AT&T -- that seemingly back that up.
A passenger who arrived on an international flight Wednesday morning had a contagious case of measles, according to health officials. The Centers for Disease Control and Prevention has contacted the people who sat next to the infected passenger on the flight.
Sinovac Biotech and Catalyst Biosciences are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation. This is a summary of current recommendations and price targets for Sinovac Biotech and Catalyst Biosciences, as provided by MarketBeat.com.
For example, here's a question that stumps even Californians who know the state well: What's the second-richest company in California after Apple? Never heard of it? You're not alone. McKesson is "a massive corporation hiding in plain sight," Fortune wrote recently.
ARDM has been the topic of several other reports. Zacks Investment Research downgraded shares of Aradigm from a "buy" rating to a "hold" rating in a research note on Wednesday, September 27th.
Some Ashkenazi Jewish women who carry a particular BRCA-1 genetic mutation have a 65 percent chance of developing breast cancer. US regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene, known as the "Jewish gene" because of its prevalence in Ashkenazi Jewish women.
Dr. Anne Wheaton, an epidemiologist and sleep program lead in the Division of Population Health at the Centers for Disease Control and Prevention, joins the podcast to discuss why Americans aren't getting enough sleep.
Firefox warnt beim Beenden des Browsers, wenn mehrere Tabs noch geöffnet sind. Damit erhält der Nutzer die Chance, eventuell benötigte Webseiten noch zu speichern. Allerdings musst du jeden offenen Tab separat anklicken. Eine automatische Speicherung kann im Meldefenster nicht ausgewählt werden. Eine Entsprechende Funktion ist zwar eingebaut, muss aber manuell aktiviert werden.
Die Warnmeldung beim Beenden des Firefox, Schließen bestätigen, enthält standardmäßig die zwei Schaltflächen Tabs schließen und Abbrechen. Bisher musste man, um die offenen Tabs zu speichern, auf Abbrechen klicken um zu dem Browser zurück zu kehren.
Durch den Eingriff über about:config wird dieser Warnmeldung ein weiterer Button, Speichern und beenden, hinzugefügt. Dieser erlaubt es, automatisch alle offenen Webseiten auf einen Schlag zu speichern.
Zur Aktivierung öffnest du einen neuen Browser-Tab, gibst in die Adresszeile about:config ein und bestätigst die nachfolgende Warnung mit dem Button Ich bin mir der Gefahren bewusst!
Gib in das Suchfeld den Begriff (oder einen Teil davon) browser.showQuitWarning ein. Den gleichnamigen Eintrag klickst du doppelt an, um den Wert von false in true zu ändern.
Ab sofort zeigt die Warnmeldung beim Beenden des Firefox den dritten Button mit der Option Speichern und beenden an. Die gesamte Sitzung wird dann beim nächsten Browser-Start wieder hergestellt.
Aber auch ohne Aktivierung des zusätzlichen Buttons kann die letzte Sitzung wieder hergestellt werden. Firefox speichert automatisch alle offenen Tabs, damit sie im Falle eines Browser-Absturzes wieder aufrufen zu können.
Klicke im Firefox oben rechts auf das Drei-Balken-Icon und wähle im Kontextmenü die Option Vorherige Sitzung wieder herstellen aus. Diese Variante erfüllt den gleichen Zweck wie der obige Button, ist aber etwas weniger komfortabel.
Hospitals nationwide are in the midst of one of the most severe medical product shortages in modern US history. With half of Puerto Rico still without power , the major medical supply giant on the island-Baxter International-has been unable to keep up with the production of the millions of IV bags upon which hospitals throughout the US mainland rely on for basic daily medical treatment of their patients.
Horizon Therapeutics and Peregrine Pharmaceuticals are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk. Peregrine Pharmaceuticals has a consensus price target of $10.00, suggesting a potential upside of 162.47%.
Iqvia and Infinity Pharmaceuticals are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations and institutional ownership. Iqvia has higher revenue and earnings than Infinity Pharmaceuticals.
According to Zacks, "Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines.
When Stephen Tower's right hip gave out in 2006, he asked his surgeon to implant an artificial one - specifically, a metal-on-metal hip called the ASR XL, made by Johnson & Johnson. He knew what he was talking about: As an orthopedic surgeon, Dr. Tower specializes in complex hip replacements.
Desktop-Verknüpfungen erlauben schnellen Zugriff auf Dateien, Verzeichnisse und Programme. Jeder Nutzer hat mit Sicherheit etliche Desktop-Icons auf seinem Monitor abgelegt. Im Gegensatz zum Windows-7-Betriebssystem wurden bei Windows 10 die Abstände zwischen den Icons vergrößert. Damit wird die Desktop-Ansicht zwar aufgelockert, es passen (rechnerisch gesehen) aber weniger Icons auf den Monitor. Über einen Registry-Eingriff lassen sich die Abstände jedoch schnell wieder auf Windows-7-Niveau bringen.
Starte das Fenster Ausführen mit der Tastenkombination [Windows][R], gib den Befehl regedit ein, und bestätige den Vorgang mit OK.
Im Registrierungseditor navigierst du dann zu dem Schlüssel HKEY_CURRENT_USER\Control Panel\Desktop\WindowMetrics.
Im rechten Anzeigebereich öffnest du nacheinander per Doppelklick die Einträge IconVerticalSpacing und IconSpacing, änderst die Werte jeweils auf -1125 und speicherst die neuen Werte mit OK.
Abschließend führst du einen Computer-Neustart durch, damit die Änderungen aktiviert werden können. Ab sofort sind die Abstände zwischen den Desktop-Icons wieder kleiner.
While your dog or cat might love the taste of raw meat, a steady diet of it might be a bad idea, a new study warns. While your dog or cat might love the taste of raw meat, a steady diet of it might be a bad idea, a new study warns.
Large cap biotech companies held a number of meetings with analysts and investors to discuss their plans for 2018, while both Celgene and Regeneron pre-announced 2017 results that were in-line to positive, compared to consensus estimates. Leerink's Geoffrey Porges and Bradley Canino take a look at the week in biotech, writing that Celgene and Regeneron were "predictably cautious" in their guidance, while the sector largely declined to estimate how tax changes will affect their profits just yet, although most companies have said that the tax bill is mostly positive.
However, the true cost of asthma is probably underestimated because the U.S. Centers for Disease Control and Prevention study did not include people with untreated asthma . The new analysis was based on federal government data, collected from 2008 to 2013.
Perkins Coie Trust Co cut its position in SPDR S&P Biotech by 12.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The fund owned 33,899 shares of the exchange traded fund's stock after selling 4,910 shares during the period.
This photo provided by AstraZeneca shows a bottle of Lynparza. On Friday, Jan. 12, 2018, the Food and Drug Administration approved AstraZeneca PLC's Lynparza, the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene.
In this Jan. 10, 2017 image, Donnie Cardenas recovers from the flu at the Palomar Medical Center in Escondido, Calif., on Wednesday, Jan. 10, 2018. The San Diego County resident said he was battling a heavy cough for days before a spike his temperature sent him into the emergency room.
Global drugmakers are looking to a tiny biotech's $850,000 therapy for a rare type of blindness as a model for getting paid for highly expensive - and effective - new medicines. Spark Therapeutics Inc plans to launch its recently approved Luxturna treatment for an inherited genetic mutation that causes blindness in March.
As the Official Bank of Daytona International SpeedwayA and ... )--Holly Energy Partners, L.P. plans to announce results for its quarter ended December 31, 2017 on February 20, 2018, before the opening of tr... )--HollyFrontier Corporation plans to announce results for its quarter ended December 31, 2017 on February 21, 2018, before the opening of trading ... )--WWE announced that its Chief Strategy & Financial Officer, George A. Barrios, will participate in a presentation at the 20th Annual Needham Growth C... )--Camden Property Trust announced today that it has completed the acquisition of a newly constructed 358-home apartment community in the Tampa/St.
Many parents still regularly risk their babies' lives as they put them to bed, according to a new report from the U.S. Centers for Disease Control and Prevention. Many parents still regularly risk their babies' lives as they put them to bed, according to a new report from the U.S. Centers for Disease Control and Prevention.
A former Insys Therapeutics Inc employee accused of engaging in a scheme to pay medical practitioners kickbacks to prescribe a fentanyl-based treatment is seeking to bar U.S. prosecutors from referring to the "opioid crisis" at his trial. Lawyers for Jeffrey Pearlman, a former district sales manager at the drugmaker, in a motion filed on Wednesday asked a federal judge in Connecticut to bar references at his trial to the crisis and evidence about the dangers opioids pose.
The Third Circuit Court of Appeals affirmed a Pennsylvania district court decision holding the Eleventh Amendment to the United States Constitution prevented a private party from enjoining the state of Louisiana from bringing claims identical to those previously thought released in a class action settlement. , in 2013 pharmaceutical giant GlaxoSmithKline settled a class action brought against it by indirect purchasers of the allergy medicine Flonase stemming from allegations the company improperly attempted to delay the introduction of a generic version of the drug.
January 11, 2018 As 2018 begins, John McCamant, editor of Medical Technology Stock Letter, reviews several 2017 top performers, discusses the turnaround at the FDA, and profiles one company with an innovative non-statin LDL cholesterol in the pipeline. In 2017, Medical Technology Stock Letter had four recommendations deliver outstanding returns led by Madrigal Pharmaceuticals Inc. with a 510% move, followed by Sangamo BioSciences Inc.'s 466% move, Esperion Therapeutics Inc. with a 416% move, and Nektar Therapeutics with a 354% move.
U.S. Centers for Disease Control and Prevention statistics show that more than 700,000 children are referred to child protective agencies as a result of abuse or neglect in the U.S. each year. According to Purva Grover, M.D., a pediatric emergency physician at Cleveland Clinic Children's, child abuse is something that unfortunately pediatricians and emergency room physicians are always on the lookout for, but parents need to know the warning signs of physical abuse too, especially when their children are left in the care of others.
The 21-year-old aspiring personal trainer filled his Facebook page with photos of himself riding motorbikes and lifting weights. He once posted an image of a kettlebell with a skeleton, reading: "CrossFit, hard to kill."
TULSA, Okla.: A federal judge in Oklahoma has dealt a blow to a Cherokee Nation lawsuit seeking to stop the flow of addictive opioid painkillers in its territory by issuing a preliminary injunction to prevent the case from being heard in tribal court. In a decision late Tuesday, U.S. District Judge Terence Kern ruled the tribal court lacked jurisdiction because the lawsuit involving six wholesale drug distributors and pharmacy operators does not directly concern tribal self-government.
The Federal Court has found that claim to be misleading and deceptive, after two pharmaceutical giants went head-to-head in a two-year legal battle. GlaxoSmithKline, the makers of Panadola , alleged Nurofen's manufacturer, Reckitt Benckisera , ran an advertising campaign saying Nurofen was faster and more effective than Panadol, or paracetamol, despite there being no scientific evidence to support it.
Did you see the Biotech sector get smashed today, with the Nasdaq Biotech ETF and the SPDR Biotech ETF , down by about 1.5 percent and 2 percent? What was that? Just look at the graph below, with Exact Sciences , down by nearly 13 percent, Exelixis down by over 7 percent, and Amicus down by more than 6 percent. Just smashed! It comes down to this, with the JPMorgan Healthcare conference ongoing, companies are pre-releasing quarterly results and outlooks for 2018, and to this point, some of the results have not been inspiring, and when you are a hyper-growth company, inline just doesn't cut it.
A Pennsylvania state court judge on Tuesday overturned a US$27.8 million jury award to an Indiana couple who accused Bayer AG and Johnson & Johnson of failing to warn of internal bleeding risks of their drug Xarelto, the companies said. FILE PHOTO: The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal, Germany February 24, 2014.
Democrats pressed President Trump's nominee to lead the Department of Health and Human Services, Alex Azar, on his ties to the pharmaceutical industry during a confirmation hearing Tuesday on Capitol Hill. HHS, which has a budget of over $1 trillion and over 80,000 employees, has been without a secretary since Tom Price resigned over his use of private jets in September.
The guidance was provided "merely suggestions of what terms to use and what often overused words should be avoided," according to the CDC. This Nov. 19, 2013 file photo shows a Centers for Disease Control and Prevention logo at the agency's federal headquarters in Atlanta.
Three Native American tribes in the Dakotas are suing opioid manufacturers and distributors, alleging they concealed and minimized the addiction risk of prescription drugs. The Rosebud Sioux Tribe, Flandreau Santee Sioux Tribe and the Sisseton Wahpeton Oyate sued 24 opioid industry groups in federal court.
Wall Street rose to fresh high at open on Tuesday, with gains for healthcare and bank stocks extending the new year rally that is powered by expectations of strong quarterly earnings. A 1.7 percent rise in Johnson & Johnson and a 5 percent jump in Boston Scientific helped the S&P health sector gain 0.7 percent.
The Centers for Disease Control and Prevention will hold a public briefing on Jan. 16 to discuss how to survive a nuclear bomb blast. Mark your calendars for Jan. 16. That's the day you can learn how to survive a nuclear blast.
ClinicalRM is a wholly owned subsidiary of ICON plc, providing full service and functional research solutions to a range of U.S. Federal Health Agencies. Dr. Cummings has over 20 years' experience within the global health and government research and development industries.
Deaths from opiates, cocaine and methamphetamines shot up by 35 percent in the United States between the year ending in May 2015 and that ending in May 2017, from about 49,000 to about 66,000, according to a Kaiser Health News analysis of statistics from the Centers for Disease Control and Prevention. The opioid crisis on the East Coast and in the Midwest has fueled a national surge in drug deaths, even as fatal overdoses have decreased or remained stable in parts of the West, new federal data show.
Illumina, Inc. announced today the launch of the iSeq 100 Sequencing System. The new, next-generation sequencing system delivers exceptional data accuracy, at a low capital cost, making Illumina technology available to virtually any lab.
** GoPro Inc is considering selling itself and has hired J.P. Morgan to help it with the process, a source familiar with the matter told Reuters. ** Celgene Corp, which has announced a deal to buy Impact Biomedicines, forecast 2018 total revenue that fell short of analysts' estimates, sending the U.S. biotech company's shares down 2 percent.
Celgene Corp on Monday forecast 2018 total revenue that fell short of analysts' estimates, sending the company's shares down 3 percent. The company, which is buying Impact Biomedicines for as much as $7 billion, said it expects full-year revenue of $14.4 billion to $14.8 billion, compared with analysts' average estimate of $14.83 billion, according to Thomson Reuters I/B/E/S.
COPENHAGEN/BRUSSELS: Denmark's Novo Nordisk, the world's biggest maker of insulin, went public with a 2.6 billion euro bid for Belgian biotech group Ablynx on Monday as it seeks to bolster its treatments for rare blood disorders. Ablynx said it rejected Novo's latest takeover approach and analysts predict the Danish group, whose new chief executive is seeking growth by buying drugs developed by competitors, might face counterbidders and would need to raise its bid.
APEIRON Biologics AG, a company focused on cancer immunotherapy, and Evotec AG announced today that the companies received the first milestone payment from Sanofi under a 3-party alliance signed in August 2015. The milestone payment of 3 million will be split equally between the two biotech companies.
Generic drugmaker Perrigo Company Plc appointed Uwe Rohrhoff, former CEO of Gerresheimer AG, as its new chief executive, the company said on Monday. Perrigo said in June Hendrickson planned to retire after a little more than a year into the job.
Last January, when thousands of biotechnology executives and investors flooded the annual J.P. Morgan Healthcare Conference, there was a tincture of anxiety amid the talk of breakthrough medicines and shrewd corporate partnerships. Donald Trump had just been elected president.
The Centers for Disease Control and Prevention is preparing for nuclear war and asking the public to do the same. To be clear, the CDC says the event of a nuclear detonation is "unlikely."
Covance is one of 189 public companies in the "Biotechnology & Medical Research" industry, but how does it compare to its competitors? We will compare Covance to similar companies based on the strength of its risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations. Covance's competitors have higher revenue, but lower earnings than Covance.
Bei Windows-10-Rechnern kommt es bisweilen zu einer erhöhten Tätigkeit des Prozessors. Hierfür ist oft der Prozess Runtime Broker verantwortlich. Eine erhöhte CPU-Last benötigt mehr Strom und belastet insbesondere die Akkus von Notebooks. Dieser Bug lässt sich schnell und einfach beseitigen.
Der Runtime Broker tritt im Zusammenhang mit der Funktion Bei der Nutzung von Windows Tipps, Tricks und Vorschläge erhalten auf und blendet in der Nähe der Taskleiste unregelmäßig Werbung ein. Kommt es hier zu einer Fehlfunktion, schaltet sich der Runtime Broker nicht ab und belastet den Prozessor.
Um die CPU-Last wieder zu normalisieren, überprüfst du mit dem Task-Manager ob der Runtime Broker in der Prozessübersicht trotz Leerlauf aktiv ist. Zur Beseitigung dieser Fehlfunktion ist die Beendigung des Prozesses nicht notwendig.
Öffne mit der Tastenkombination [Windows][I] nun die Einstellungen und klicke nacheinander auf System | Benachrichtigungen und Aktionen. Anschließend scrollst du im mittleren Anzeigebereich zu den Benachrichtigungen und deaktivierst das Feature Bei der Nutzung von Windows Tipps, Tricks und Vorschläge erhalten über den dazugehörigen Schalter.
Abschließend startest du den Computer neu, damit Windows die Änderung speichern kann. Ab sofort sollte der Prozess Runtime Broker keine Probleme mehr machen.
